Featured

Status

All Statuses
  • Withdrawn1

Health Topics

Any Category
Diseases
Immune System Diseases
Immunoproliferative Disorders
Lymphoproliferative Disorders
Lymphoma
Clear Filters

Search Clinical Trials

1 Result
Withdrawn
Administration of T Lymphocytes for Hodgkin's Lymphoma and Non-Hodgkin's Lymphoma (CART CD30)
When the patient enrolls on this study, they will be assigned a dose of CD30 chimeric receptor-activated T cells. The dose level of cells that they will receive will not …
Baylor Role: Collaborator